Relay Therapeutics RLAY - Options Chain | ADVFN

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Relay Therapeutics Inc (RLAY)
Relay Therapeutics Inc (RLAY) Options

Relay Therapeutics Inc (RLAY)

8.27

0.03

(0.36%)

Closed July 16 4:00PM

Delayed by 15 minutes

8.27

0.00

(0.00%)

After Hours: 7:59PM

Delayed by 15 minutes

RLAY Options Flow

Calls

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
2.50	4.10	8.00	0.00	6.05	0.00	0.00 %	0	0	-
5.00	1.45	5.50	0.00	3.475	0.00	0.00 %	0	0	-
7.50	0.70	3.70	0.80	2.20	0.00	0.00 %	5	80	7/15/2024
10.00	0.05	0.10	0.10	0.075	0.00	0.00 %	10	24	7/15/2024
12.50	0.00	0.75	0.00	0.00	0.00	0.00 %	0	0	-

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Puts

Strike	Bid Price	Ask Price	Last Price	Midpoint	Change	Change %	Volume	OPEN INT	Last Trade
2.50	0.00	0.75	0.00	0.00	0.00	0.00 %	0	0	-
5.00	0.05	0.75	0.05	0.40	0.00	0.00 %	0	0	-
7.50	0.00	2.85	0.00	0.00	0.00	0.00 %	0	0	-
10.00	1.30	4.60	0.00	2.95	0.00	0.00 %	0	0	-
12.50	3.60	4.80	0.00	4.20	0.00	0.00 %	0	0	-

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
AMIXAutonomix Medical Inc	$ 1.3701 (121.70%)	154.81M
SHOTWSafety Shot Inc	$ 0.41 (115.79%)	7.56k
DATSDatChat Inc	$ 1.89 (81.73%)	54.75M
CYNCYNGN Inc	$ 9.18 (53.77%)	17.79M
SCNIScinai Immunotherapeutics Ltd	$ 5.80 (42.86%)	29.37M
ASLNASLAN Pharmaceuticals Ltd	$ 1.36 (-46.67%)	1.16M
KZIAKazia Therapeutics Ltd	$ 0.5593 (-37.56%)	15.34M
LCFYLocafy Ltd	$ 3.5597 (-36.32%)	584.38k
NAASNaaS Technology Inc	$ 2.82 (-33.02%)	1.94M
ZENVZenvia Inc	$ 1.67 (-26.75%)	658.26k
FFIEFaraday Future Intelligent Electric Inc	$ 0.5152 (22.09%)	217.92M
NVDANVIDIA Corporation	$ 128.44 (-0.62%)	208.32M
SQQQProShares UltraPro Short QQQ	$ 7.46 (-0.67%)	155.14M
AMIXAutonomix Medical Inc	$ 1.3701 (121.70%)	154.81M
TSLATesla Inc	$ 252.64 (1.78%)	147.31M

Monksdream

Monksdream 4 months ago

Monksdream

Monksdream 1 year ago

Using AI to find the next blockbuster drug
This week, AI chipmaker Nvidia placed their bet — investing $50M into AI drug discovery platform Recursion Pharmaceuticals (NASDAQ:RXRX) — sending its stock up 78%.

Drugmakers are already benefiting from using AI to discover new drugs. And in the process, AI is speeding up and reducing the cost of the long and expensive drug development process.
Between 2015 and 2022, the cumulative investment in AI drug development has risen from under $1B to $24.6B.
In the next decade, Morgan Stanley expects AI will help develop an additional 50 drugs with an extra $50B in sales.
Following Nvidia’s investment, other AI drug discovery platforms rose on the news, including Exscientia (NASDAQ:EXAI), AbCellera Biologics (NASDAQ:ABCL) and Relay Therapeutics (NASDAQ:RLAY).
Recursion has five drugs, and Exscientia has three drugs discovered with AI, which are already in human trials. And within the startup sector, AI drug discovery has quickly become one of the hottest markets for investment.

Relay Therapeutics

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions